Roy A. Whitfield's Insider Trades & SAST Disclosures

Roy A. Whitfield's most recent trade in Nektar Therapeutics was a trade of 8,000 Stock Option done . Disclosure was reported to the exchange on Sept. 30, 2025.

Share

Note

This is a custom search result for pattern Roy A. Whitfield.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Nektar Therapeutics Board Meeting	Roy A. Whitfield	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2025	8,000	8,000	-		-	Stock Option
Nektar Therapeutics Board Meeting	Roy A. Whitfield	Director		31 Dec 2024	120,000	120,000	-		-	Stock Option
Nektar Therapeutics Board Meeting	Roy A. Whitfield	Director	Sale of securities on an exchange or to another person at price $ 0.57 per share.	14 Jun 2023	30,000	216,250 (0%)	0%	0.6	17,100	Common Stock
Nektar Therapeutics Board Meeting	Roy A. Whitfield	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2022	20,400	20,400	-		-	Stock Option
Nektar Therapeutics Board Meeting	Roy A. Whitfield	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2022	10,200	246,250 (0%)	0%		0	Common Stock
Nektar Therapeutics Board Meeting	Roy A. Whitfield	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Sep 2021	20,400	20,400	-		-	Stock Option
Nektar Therapeutics Board Meeting	Roy A. Whitfield	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Sep 2021	10,200	236,050 (0%)	0%		0	Common Stock
Nektar Therapeutics Board Meeting	Roy A. Whitfield	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.80 per share.	16 Sep 2021	40,000	225,850 (0%)	0%	13.8	552,000	Common Stock
Nektar Therapeutics Board Meeting	Roy A. Whitfield	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Sep 2021	40,000	0	-		-	Stock Option

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades